GE HealthCare Technologies Inc. (GEHC) is a Healthcare stock trading at $74.04 (as of 2026-08-20), with a market capitalization of $33.68B and a trailing P/E of 17.6. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
GE HealthCare Technologies Inc. develops, manufactures, and markets medical products, services, and complementary digital solutions for diagnosis, treatment, and patient monitoring in multiple regions including the United States, Canada, Europe, the Middle East and Africa, and parts of Asia. It operates across Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics segments.
GE HealthCare sells medical imaging, ultrasound, patient care solutions, and pharmaceutical diagnostics used to diagnose, treat, and monitor patients, and it makes money by selling these products and related digital solutions to healthcare providers and customers.
GE HealthCare's profit visibility depends on converting a large backlog of work, reflected in Remaining Performance Obligations (USD_B 14.5), into delivered Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics revenue.
| Imaging | $2.3B |
| Ultrasound | $0.8B |
| Patient Care Solutions | $0.7B |
| Pharmaceutical Diagnostics | $0.8B |
Business quality (Mixed): Clear official segment categories are provided, and key operating signals include backlog and order flow, but the provided segment revenue figures do not exactly sum to the stated total revenue (5.1B), which suggests rounding or unallocated items.
Valuation: At 15× earnings, GEHC trades 54% below the Medical Equipment average (32×). Note: one-time items can distort reported P/E.
| Price | $74.04 |
| Market Cap | $33.68B |
| P/E Ratio | 17.6 |
| EV / EBITDA | 14.1 |
| Price / Book | 3.15 |
| Price / Sales | 1.61 |
| FCF Yield | 0.6% |
| DCF Value (model) | $49.92 |
| DCF Upside vs Price | -32.6% |
| Revenue (TTM) | $20.63B |
| Net Margin | 10.1% |
| Revenue Growth (YoY) | 7.4% |
| EPS Growth (YoY) | -30.9% |
| FCF Growth (YoY) | 14.3% |
| Altman Z-Score | 1.88 (grey) |
| Stock P/E | 17.6 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Medical Equipment) | 32.9 |
| vs Sector | -18.3% |
| vs Industry | -46.3% |
| Top Institutional Holder | VANGUARD GROUP INC ($4.29B) |
| Institutional Holders Tracked | 10 |
| Congressional Trades (recent) | 7 |
| Sector | Healthcare |
| Industry | Medical Equipment |
| CEO | Peter J. Arduini |
| Employees | 53,000 |
| Country | US |
| IPO Date | 2022-12-15 |
Data as of 2026-08-20.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.